prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2008
-
Detection and treatment of molecular relapse in acute myeloid leukemia (AML) with frequent quantitative monitoring of molecular markersin different comprartments
Transfuze a hematologie dnes, year: 2008, volume: 14, edition: Suppl. 1
-
Detection and treatment of molecular relapse in acute myeloid leukemia with RUNXa, CBFB, MLL gene translocations, or NPMI mutation. Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
Annals of Hematology, year: 2008, volume: 87, edition: 1
-
Detekce genomických aberací u B-CLL pacientů metodou array CGH
Transfuze a hematologie dnes, year: 2008, volume: 14, edition: Suppl. 2
-
Diagnostika esenciální trombocytemie. Definice esenciální trombocytemie (ET) a trombocytemie provázející další Ph negativní myeloproliferativní choroby (MPO).
Transfuze a hematologie dnes, year: 2008, volume: 14, edition: Suppl. 1
-
Heterozygotní delece ATM nezvyšuje rezistenci CLL buněk na fludarabin
Year: 2008, type: Conference abstract
-
High Expression of LAG3, LPL and ZAP-70 Genes in B-CLL Strongly Correlates with Unmutated IgVH and Early Therapy Requirement
Blood, year: 2008, volume: 112, edition: 11
-
Chlorambucil and fludarabine as a new pre-transplant conditioning for patients with chronic lymphocytic leukemia: results of in vivo experiments.
Veterinarni Medicina, year: 2008, volume: 53, edition: 10
-
Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia
Molecular Immunology, year: 2008, volume: 45, edition: 5
-
Imatinib in the first-line cml treatment: an analysis of a comprehensive non-commercial database of all consecutive patients in a defined population
Year: 2008, type: Conference abstract
-
Imatinib v první linii léčby nemocných s chronickou myeloidní leukemií (CML) v první chronické fázi: analýza dat z registru Infinity
Year: 2008, type: Conference abstract